Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.01 (+4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Net Preferred Shares Issued and Repurchased (2020 - 2021)

Updated

Analysis

Context Therapeutics (CNTX) Net Preferred Shares Issued and Repurchased (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Context Therapeutics 21.82 Mn -218.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1.95 Mn
Mar 31, 2021 3.03 Mn
Dec 31, 2020 350,000.00
API Access

Context Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CNTX&period=max&api_key=YOUR_API_KEY